Metabolism of cisplatin to a nephrotoxin

Toxicology

Volumn 257, Issue 3, 2009, Pages 174-175

  Hanigan, Marie H ^a   Townsend, Danyelle M ^b   Cooper, Arthur J L ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIVICIN; AMINOOXYACETIC ACID; ASPARTATE AMINOTRANSFERASE; BESTATIN; CISPLATIN; CYSTEINYLGLYCINE; CYTOSOL AMINOPEPTIDASE; DIPEPTIDASE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMINE PHENYLPYRUVATE AMINOTRANSFERASE; NEPHROTOXIC AGENT; PHENYLALANYLGLYCINE; TOXIN; UNCLASSIFIED DRUG;

BIOTRANSFORMATION; C57BL 6 MOUSE; CELL VIABILITY; DRUG ACTIVITY; DRUG METABOLISM; KIDNEY CELL; LETTER; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CARBON-SULFUR LYASES; CELLS, CULTURED; CISPLATIN; ENZYME INHIBITORS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; ISOXAZOLES; KIDNEY DISEASES; LYASES; MICE; RATS; TRANSAMINASES;

EID: 60249086928     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.12.014     Document Type: Letter

References (13)

1. Cooper A.J.L. Purification of soluble and mitochondrial glutamine transaminase K from rat kidney. Use of a sensitive assay involving transamination between l-phenylalanine and alpha-keto-gamma-methiolbutyrate. Anal. Biochem. 89 (1978) 451-460
2. Cooper A.J.L., and Pinto J.T. Cysteine S-conjugate beta-lyases. Amino Acids 30 (2006) 1-15
3. Hanigan M.H., Gallagher B.C., Taylor Jr. P.T., and Large M.K. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res. 54 (1994) 5925-5929
4. Hanigan M.H., Gallagher B.C., and Taylor Jr. P.T. Cisplatin, nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney. Am. J. Obstet. Gynecol. 175 (1996) 270-274
5. Hanigan M.H., Lykissa E.D., Townsend D.M., Ou C.N., Barrios R., and Lieberman M.W. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am. J. Pathol. 159 (2001) 1889-1894
6. Josch C., Klotz L.O., and Sies H. Identification of cytosolic leucyl aminopeptidase (EC 3.4. 11. 1) as the major cysteinylglycine-hydrolysing activity in rat liver. Biol. Chem. 384 (2003) 213-218
7. McGoldrick T.A., Lock E.A., Rodilla V., and Hawksworth G.M. Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells. Arch. Toxicol. 77 (2003) 365-370
8. Townsend D.M., and Hanigan M.H. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J. Pharmacol. Exp. Ther. 300 (2002) 142-148
9. Townsend D.M., Deng M., Zhang L., Lapus M.G., and Hanigan M.H. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J. Am. Soc. Nephrol. 14 (2003) 1-10
10. Townsend D.M., Marto J.A., Deng M., Macdonald T.J., and Hanigan M.H. High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of Cisplatin. Drug Metab. Dispos. 31 (2003) 705-713
11. Wainford R.D., Weaver R.J., Stewart K.N., Brown P., and Hawksworth G.M. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. Tox 249 (2008) 184-193
12. Zhang L., and Hanigan M.H. Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin. J. Pharmacol. Exp. Ther. 306 (2003) 988-994
13. Zhang L., Cooper A.J.L., Krasnikov B.F., Xu H., Bubber P., Pinto J.T., Gibson G.E., and Hanigan M.H. Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells. Biochemistry 45 (2006) 8959-8971